Drug Combo Marks Advance Against Bladder Cancer
MONDAY, March 11, 2024 -- A cancer drug duo more than doubled the survival of people battling the most common form of advanced bladder cancer, trial results show.Patients who took a combo of meds called EV+P -- enfortumab vedotin and pembrolizumab...
What's Your Reaction?